Advertisement

Doklady Biological Sciences

, Volume 453, Issue 1, pp 333–335 | Cite as

Effect of the PRO-GLY-PRO peptide on hemostasis and lipid metabolism in rats with hypercholesterolemia

  • L. A. Andreeva
  • N. F. Myasoedov
  • L. A. Lyapina
  • M. E. Grigor’eva
  • T. Yu. Obergan
  • T. A. Shubina
Physiology

Keywords

Fibrinogen Platelet Aggregation Tissue Plasminogen Activator Activate Partial Thromboplastin Time Intranasal Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martsevich, S.Yu., Ateroskleroz. Klinicheskaya znachimost’ i vozmozhnost’ preduprezhdeniya (Atherosclerosis: Clinical Significance and the Possibility of Prevention), Moscow: Serviskom, 2005.Google Scholar
  2. 2.
    Xiao, C., Hsieh, J., and Adeli, K., Am. J. Physiol. Endocrinol. Metab., 2011, vol. 301, pp. E429–E446.PubMedCrossRefGoogle Scholar
  3. 3.
    Li, E.D., Lazebnik, L.B., and Konopleva, G.E., Mezhd. Med. Zh., 2000, no. 3, pp. 265–268.Google Scholar
  4. 4.
    Ashmarin, I.P., Patologicheskaya fiziologiya i biokhimiya (Pathological Physiology and Biochemistry), Moscow: Ekzamen, 2005.Google Scholar
  5. 5.
    Watson, T., Arya, A., and Sulke, N., Chest, 2010, vol. 137, pp. 869–876.PubMedCrossRefGoogle Scholar
  6. 6.
    Egger, E., Schmid, J.P., and Schmid, R.W., Eur. J. Cardiovasc. Prevent. Rehabil., 2008, no. 15, pp. 704–708.Google Scholar
  7. 7.
    Kostapanos, M.S., Haralampos, J.M., and Moses, S., J. Cardiovasc. Pharmacol. Ther., 2008, no. 13, pp. 157–174.Google Scholar
  8. 8.
    Myasoedov, N.F., Andreeva, L.A., Lyapina, L.A., Ul’yanov, A.M., Shubina, T.A., Obergan, T.K., Pastorova, V.E., and Grigor’eva, M.E., Dokl. Biol. Sci., 2011, vol. 438, no. 2, pp. 135–137.PubMedCrossRefGoogle Scholar
  9. 9.
    Lyapina, L.A., Pastorova, V.E., Obergan, T.Yu., et al., Izv. Akad. Nauk, Ser. Biol., 2006, no. 2, pp. 193–203.Google Scholar
  10. 10.
    Lyapina, L.A., Grigor’eva, M.E., Obergan, T.Yu., and Shubina, T.A., Teoreticheskie i prakticheskie voprosy izucheniya funktsional’nogo sostoyaniya protivosvertyvayushchei sistemy (The Theoretical and Practical Bases of the Study of the Functional State of the Anticoagulant System), Moscow: Advanced Solution, 2012.Google Scholar
  11. 11.
    Dolgov, V.V. and Svirin, P.V., Laboratornaya diagnostika narushenii gemostaza (Laboratory Diagnosis of Homeostatic Disorders), Moscow: Triada, 2005.Google Scholar
  12. 12.
    Berkovskii, A.L., Vasil’ev, S.A., and Zherdeva, L.V., Posobie po izucheniyu adgezivno-agregatsionnoi aktivnosti trombotsitov (Study of the Adhesion-Aggregation Activity of Platelets: A Textbook), Moscow: Ross. Akad. Med. Nauk, 2003.Google Scholar
  13. 13.
    Barkagan, Z.S. and Momot, A.P., Diagnostika i kontroliruemaya terapiya narushenii gemostaza (Diagnosis and Controllable Therapy of Homeostatic Disorders), Moscow: N’yudiamed, 2001.Google Scholar
  14. 14.
    Solin, A.V., Korozin, V.I., and Lyashev, Yu.D., Byull. Eksp. Biol. Med., 2013, no. 3, pp. 299–301.Google Scholar
  15. 15.
    Aviram, M., Brook, J.G., Lees, A.M., et al., Biochem. Biophys. Res. Commun., 1981, vol. 99, no. 1, pp. 308–318.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2013

Authors and Affiliations

  • L. A. Andreeva
    • 1
  • N. F. Myasoedov
    • 1
  • L. A. Lyapina
    • 1
  • M. E. Grigor’eva
    • 1
  • T. Yu. Obergan
    • 1
  • T. A. Shubina
    • 1
  1. 1.Institute of Molecular GeneticsRussian Academy of SciencesMoscowRussia

Personalised recommendations